Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
23 August 1989Website:
http://www.neogen.comNext earnings report:
09 January 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 23:13:48 GMTDividend
Analysts recommendations
Institutional Ownership
NEOG Latest News
Neogen reported its Q1 earnings, which missed expectations. Weak demand trends across food and animal safety end markets have pressured the sales outlook. We expect shares to remain volatile until there is evidence of a growth rebound.
Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Neogen Corporation (NASDAQ:NEOG ) Q1 2025 Earnings Conference Call October 10, 2024 8:00 AM ET Company Participants Bill Waelke - Vice President, Investor Relations & Treasury John Adent - Chief Executive Officer Dave Naemura - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Brandon Vazquez - William Blair Thomas DeBourcy - Nephron Research Operator Good morning, ladies and gentlemen, and welcome to the Neogen Corporation First Quarter 2025 Earnings Call. At this time, all lines are in listen-only mode.
Neogen (NEOG) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.11 per share a year ago.
Revenue of $217.0 million. Net loss of $12.6 million; $(0.06) per diluted share.
Evaluate the expected performance of Neogen (NEOG) for the quarter ended August 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
LANSING, Mich. , Sept. 19, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release before the opening of the market on Thursday, October 10, 2024.
Investors need to pay close attention to Neogen (NEOG) stock based on the movements in the options market lately.
LEXINGTON, Ky. , Aug. 22, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that it has formed a relationship with US Equestrian to help provide better equine care solutions for veterinarians and horse owners.
Investors need to pay close attention to Neogen (NEOG) stock based on the movements in the options market lately.
What type of business is Neogen?
Neogen Corporation produces and sells products for ensuring the safety of food products and animals. The company operates in two main segments: The Food Safety segment offers diagnostic test kits and related products for detecting harmful substances in food products and animal feed, including foodborne pathogens, parasites, toxins, food allergens, genetic modifications, and by-products of ruminant animals. The Animal Safety segment is involved in the development, manufacturing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topical treatments, and diagnostic products. Neogen Corporation was founded in 1981, with its headquarters located in Lansing, Michigan.
What sector is Neogen in?
Neogen is in the Healthcare sector
What industry is Neogen in?
Neogen is in the Diagnostics & Research industry
What country is Neogen from?
Neogen is headquartered in United States
When did Neogen go public?
Neogen initial public offering (IPO) was on 23 August 1989
What is Neogen website?
https://www.neogen.com
Is Neogen in the S&P 500?
No, Neogen is not included in the S&P 500 index
Is Neogen in the NASDAQ 100?
No, Neogen is not included in the NASDAQ 100 index
Is Neogen in the Dow Jones?
No, Neogen is not included in the Dow Jones index
When was Neogen the previous earnings report?
No data
When does Neogen earnings report?
The next expected earnings date for Neogen is 09 January 2025